It's hard to believe that after all these years, we are sitting at $360M, when 1 to 2 billion is more like it. Still lingering with OTC-like companies. That turning point we have all been waiting for hasn't happened to this company. That step up to join the elite hasn't happened to this company. Noone is taking us seriously until we start reporting 20-30 M in sales per Q.
News 
Market Data 
Discover 
